Outcome of Board Meeting held on Jun 06, 2026

Gujarat Themis Biosyn Limited's Board of Directors has approved raising up to Rs. 1,000 Crores through a Qualified Institutions Placement (QIP) and/or other permissible modes, subject to shareholder and regulatory approvals. Additionally, the company plans to raise funds through a preferential issue of equity shares to Non-Promoters, also pending necessary approvals.

Reported results are the point at which prior management commitments become checkable against audited or reviewed numbers.

• Margin trend against the prior period
• Cash from operations against reported profit
• Whether prior guidance is reaffirmed
• The transaction is expected to close by the end of Q3FY27 (Quarter Ending 31st December 2026), subject to cust (management committed by Q3 FY27)